ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement

Giovanni Pulignano, Michele Massimo Gulizia, Samuele Baldasseroni, Francesco Bedogni, Giovanni Cioffi, Ciro Indolfi, Francesco Romeo, Adriano Murrone, Francesco Musumeci, Alessandro Parolari, Leonardo Patanè, Paolo Giuseppe Pino, Annalisa Mongiardo, Carmen Spaccarotella, Roberto Di Bartolomeo, Giuseppe Musumeci

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aortic stenosis is one of the most frequent valvular diseases in developed countries, and its impact on public health resources and assistance is increasing. A substantial proportion of elderly people with severe aortic stenosis is not eligible to surgery because of the advanced age, frailty, and multiple co-morbidities. Transcatheter aortic valve implantation (TAVI) enables the treatment of very elderly patients at high or prohibitive surgical risk considered ineligible for surgery and with an acceptable life expectancy. However, a significant percentage of patients die or show no improvement in quality of life (QOL) in the follow-up. In the decision-making process, it is important to determine: (i) whether and how much frailty of the patient influences the risk of procedures; (ii) how the QOL and the individual patient's survival are influenced by aortic valve disease or from other associated conditions; and (iii) whether a geriatric specialist intervention to evaluate and correct frailty or other diseases with their potential or already manifest disabilities can improve the outcome of surgery or TAVI. Consequently, in addition to risk stratification with conventional tools, a number of factors including multi-morbidity, disability, frailty, and cognitive function should be considered, in order to assess the expected benefit of both surgery and TAVI. The pre-operative optimization through a multidisciplinary approach with a Heart Team can counteract the multiple damage (cardiac, neurological, muscular, respiratory, and kidney) that can potentially aggravate the reduced physiological reserves characteristic of frailty. The systematic application in clinical practice of multidimensional assessment instruments of frailty and cognitive function in the screening and the adoption of specific care pathways should facilitate this task.

Original languageEnglish
Pages (from-to)D354-D369
JournalEuropean Heart Journal, Supplement
Volume19
DOIs
Publication statusPublished - May 1 2017

Fingerprint

Aortic Valve Stenosis
Consensus
Cognition
Public Assistance
Quality of Life
Morbidity
Aortic Diseases
Health Resources
Life Expectancy
Aortic Valve
Developed Countries
Geriatrics
Decision Making
Public Health
Kidney
Survival
Transcatheter Aortic Valve Replacement
Therapeutics

Keywords

  • Aortic stenosis
  • Elderly
  • Frailty
  • Geriatric assessment
  • Prognosis
  • Risk score
  • SAVR
  • TAVI

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement. / Pulignano, Giovanni; Gulizia, Michele Massimo; Baldasseroni, Samuele; Bedogni, Francesco; Cioffi, Giovanni; Indolfi, Ciro; Romeo, Francesco; Murrone, Adriano; Musumeci, Francesco; Parolari, Alessandro; Patanè, Leonardo; Pino, Paolo Giuseppe; Mongiardo, Annalisa; Spaccarotella, Carmen; Di Bartolomeo, Roberto; Musumeci, Giuseppe.

In: European Heart Journal, Supplement, Vol. 19, 01.05.2017, p. D354-D369.

Research output: Contribution to journalArticle

Pulignano, G, Gulizia, MM, Baldasseroni, S, Bedogni, F, Cioffi, G, Indolfi, C, Romeo, F, Murrone, A, Musumeci, F, Parolari, A, Patanè, L, Pino, PG, Mongiardo, A, Spaccarotella, C, Di Bartolomeo, R & Musumeci, G 2017, 'ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement', European Heart Journal, Supplement, vol. 19, pp. D354-D369. https://doi.org/10.1093/eurheartj/sux012
Pulignano, Giovanni ; Gulizia, Michele Massimo ; Baldasseroni, Samuele ; Bedogni, Francesco ; Cioffi, Giovanni ; Indolfi, Ciro ; Romeo, Francesco ; Murrone, Adriano ; Musumeci, Francesco ; Parolari, Alessandro ; Patanè, Leonardo ; Pino, Paolo Giuseppe ; Mongiardo, Annalisa ; Spaccarotella, Carmen ; Di Bartolomeo, Roberto ; Musumeci, Giuseppe. / ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement. In: European Heart Journal, Supplement. 2017 ; Vol. 19. pp. D354-D369.
@article{819a0b5206594b70a1317d593a050721,
title = "ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement",
abstract = "Aortic stenosis is one of the most frequent valvular diseases in developed countries, and its impact on public health resources and assistance is increasing. A substantial proportion of elderly people with severe aortic stenosis is not eligible to surgery because of the advanced age, frailty, and multiple co-morbidities. Transcatheter aortic valve implantation (TAVI) enables the treatment of very elderly patients at high or prohibitive surgical risk considered ineligible for surgery and with an acceptable life expectancy. However, a significant percentage of patients die or show no improvement in quality of life (QOL) in the follow-up. In the decision-making process, it is important to determine: (i) whether and how much frailty of the patient influences the risk of procedures; (ii) how the QOL and the individual patient's survival are influenced by aortic valve disease or from other associated conditions; and (iii) whether a geriatric specialist intervention to evaluate and correct frailty or other diseases with their potential or already manifest disabilities can improve the outcome of surgery or TAVI. Consequently, in addition to risk stratification with conventional tools, a number of factors including multi-morbidity, disability, frailty, and cognitive function should be considered, in order to assess the expected benefit of both surgery and TAVI. The pre-operative optimization through a multidisciplinary approach with a Heart Team can counteract the multiple damage (cardiac, neurological, muscular, respiratory, and kidney) that can potentially aggravate the reduced physiological reserves characteristic of frailty. The systematic application in clinical practice of multidimensional assessment instruments of frailty and cognitive function in the screening and the adoption of specific care pathways should facilitate this task.",
keywords = "Aortic stenosis, Elderly, Frailty, Geriatric assessment, Prognosis, Risk score, SAVR, TAVI",
author = "Giovanni Pulignano and Gulizia, {Michele Massimo} and Samuele Baldasseroni and Francesco Bedogni and Giovanni Cioffi and Ciro Indolfi and Francesco Romeo and Adriano Murrone and Francesco Musumeci and Alessandro Parolari and Leonardo Patan{\`e} and Pino, {Paolo Giuseppe} and Annalisa Mongiardo and Carmen Spaccarotella and {Di Bartolomeo}, Roberto and Giuseppe Musumeci",
year = "2017",
month = "5",
day = "1",
doi = "10.1093/eurheartj/sux012",
language = "English",
volume = "19",
pages = "D354--D369",
journal = "European Heart Journal, Supplement",
issn = "1520-765X",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement

AU - Pulignano, Giovanni

AU - Gulizia, Michele Massimo

AU - Baldasseroni, Samuele

AU - Bedogni, Francesco

AU - Cioffi, Giovanni

AU - Indolfi, Ciro

AU - Romeo, Francesco

AU - Murrone, Adriano

AU - Musumeci, Francesco

AU - Parolari, Alessandro

AU - Patanè, Leonardo

AU - Pino, Paolo Giuseppe

AU - Mongiardo, Annalisa

AU - Spaccarotella, Carmen

AU - Di Bartolomeo, Roberto

AU - Musumeci, Giuseppe

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Aortic stenosis is one of the most frequent valvular diseases in developed countries, and its impact on public health resources and assistance is increasing. A substantial proportion of elderly people with severe aortic stenosis is not eligible to surgery because of the advanced age, frailty, and multiple co-morbidities. Transcatheter aortic valve implantation (TAVI) enables the treatment of very elderly patients at high or prohibitive surgical risk considered ineligible for surgery and with an acceptable life expectancy. However, a significant percentage of patients die or show no improvement in quality of life (QOL) in the follow-up. In the decision-making process, it is important to determine: (i) whether and how much frailty of the patient influences the risk of procedures; (ii) how the QOL and the individual patient's survival are influenced by aortic valve disease or from other associated conditions; and (iii) whether a geriatric specialist intervention to evaluate and correct frailty or other diseases with their potential or already manifest disabilities can improve the outcome of surgery or TAVI. Consequently, in addition to risk stratification with conventional tools, a number of factors including multi-morbidity, disability, frailty, and cognitive function should be considered, in order to assess the expected benefit of both surgery and TAVI. The pre-operative optimization through a multidisciplinary approach with a Heart Team can counteract the multiple damage (cardiac, neurological, muscular, respiratory, and kidney) that can potentially aggravate the reduced physiological reserves characteristic of frailty. The systematic application in clinical practice of multidimensional assessment instruments of frailty and cognitive function in the screening and the adoption of specific care pathways should facilitate this task.

AB - Aortic stenosis is one of the most frequent valvular diseases in developed countries, and its impact on public health resources and assistance is increasing. A substantial proportion of elderly people with severe aortic stenosis is not eligible to surgery because of the advanced age, frailty, and multiple co-morbidities. Transcatheter aortic valve implantation (TAVI) enables the treatment of very elderly patients at high or prohibitive surgical risk considered ineligible for surgery and with an acceptable life expectancy. However, a significant percentage of patients die or show no improvement in quality of life (QOL) in the follow-up. In the decision-making process, it is important to determine: (i) whether and how much frailty of the patient influences the risk of procedures; (ii) how the QOL and the individual patient's survival are influenced by aortic valve disease or from other associated conditions; and (iii) whether a geriatric specialist intervention to evaluate and correct frailty or other diseases with their potential or already manifest disabilities can improve the outcome of surgery or TAVI. Consequently, in addition to risk stratification with conventional tools, a number of factors including multi-morbidity, disability, frailty, and cognitive function should be considered, in order to assess the expected benefit of both surgery and TAVI. The pre-operative optimization through a multidisciplinary approach with a Heart Team can counteract the multiple damage (cardiac, neurological, muscular, respiratory, and kidney) that can potentially aggravate the reduced physiological reserves characteristic of frailty. The systematic application in clinical practice of multidimensional assessment instruments of frailty and cognitive function in the screening and the adoption of specific care pathways should facilitate this task.

KW - Aortic stenosis

KW - Elderly

KW - Frailty

KW - Geriatric assessment

KW - Prognosis

KW - Risk score

KW - SAVR

KW - TAVI

UR - http://www.scopus.com/inward/record.url?scp=85028302440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028302440&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/sux012

DO - 10.1093/eurheartj/sux012

M3 - Article

VL - 19

SP - D354-D369

JO - European Heart Journal, Supplement

JF - European Heart Journal, Supplement

SN - 1520-765X

ER -